Company violated chemical waste release norms
“We have served a closure order on the company unit a couple of days ago as it is violating chemical waste release norms,’’ Bhaskara Rao, a senior taskforce official of the Andhra Pradesh Pollution Control Board (APPCB), told Business Line.
Acting on complaints from the locals, APPCB officials inspected the unit and ‘found’ that the company was releasing chemical wastes into the nalas (drains) in violation of the norms.
The Indian subsidiary is vital for Mylan, one of the world’s largest producers of active pharmaceutical ingredient (API), used to make generic antiretroviral (ARV) therapies for the treatment of HIV/AIDS. “This relationship makes Mylan one of the only two global generics companies with a comprehensive, vertically integrated supply chain,’’ it says on its official portal.
Headquartered in Hyderabad, Mylan Laboratories operates nine API and intermediate manufacturing plants in India and China.
According to the procedure, the company has to stop production with immediate effect.
It can resume manufacturing operations only after addressing the issues raised by the APPCB and has to get the closure order lifted.